Longer diabetes duration lowers likelihood for meeting glyce
People with a longer duration of diabetes are less likely to achieve glycemic targets, according to a study published in Journal of Diabetes and Its Complications.

Researchers objective was to examine risk factor modification targets and treatment in relation to duration of diabetes.

The Diabetes Mellitus Status in Canada (DM-SCAN) study collected data on 5109 patients with type 2 diabetes mellitus (T2DM) in 2012 in primary care. It compared the prevalence of vascular complications, treatment targets, and interventions between patients with diagnosed diabetes duration less than 10 and more than 10 years.

-- Physicians more frequently assigned HbA1c (glycated hemoglobin) targets of 7.1–8.5% (54–69 mmol/mol) to patients with longer duration of diabetes (n = 1647) (19.8% vs 9.5%).

-- Patients with longer duration of diabetes were less likely to achieve HbA1c targets of less than 7.0% (53 mmol/mol) (39% vs. 55%), had similar likelihood of achieving blood pressure targets of less than 130/80 mmHg (38% vs. 36%) and were more likely to achieve LDL-C targets of less than 2.0 mmol/L (less than 77.3 mg/dL) (63% vs. 53%) compared to patients with shorter duration of diabetes (n = 3462).

-- Achievement of all three targets between both groups were similar (13% vs. 13%).

-- Overall, patients with longer duration of diabetes were more likely to be prescribed anti-hyperglycemic, anti-hypertensive, lipid-lowering medications and referred for diabetes education.

Conclusively, only 13% of patients achieved glycemic, blood pressure, and LDL-C targets irrespective of duration of diabetes. Despite being managed with more medications, patients with longer duration of diabetes were less likely to achieve glycemic targets. More focus is needed on developing methods to bridge best care and real-world practice.

Source: https://www.sciencedirect.com/science/article/abs/pii/S1056872721001975?via=ihub